CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The effect of multimodal therapy on time to progression (TTP) and overall survival (OS) in unresectable locally advanced non-metastatic pancreatic cancer (LANMPC)
DOI 10.1055/s-2005-869649
Bibliografische Angaben
Nachweis in CareLit
Autor:innenY Al-Farhat, J Hadjiev, D Kelemen, K Hideghéti, T Csere, K Stefanits, M Eleméry, Ö Horváth, I Repa, O Ésik
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Pancreatic cancer is difficult to treat and almost impossible to screen for. Surgical resection offers the best possibility for cure, however, only 15–20% of patients are diagnosed with the disease at a resectable stage. We initiated a multimodal regimen to investigate the TTP and OS for patients with LANMPC. Methods: Between January 2003 and January 2005 21 unresectable patients were treated with LANMPC…
Zitieren
Zitierempfehlung
Y Al-Farhat, J Hadjiev, D Kelemen, K Hideghéti, T Csere, K Stefanits, M Eleméry, Ö Horváth, I Repa, O Ésik (2005) The effect of multimodal therapy on time to progression (TTP) and overall survival (OS) in unresectable locally advanced non-metastatic pancreatic cancer (LANMPC). Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2005-869649
Mit CareLit weiterarbeiten